[go: up one dir, main page]

YU188691A - Neparosan-n,0-sulfati i postupak za njihovo dobijanje - Google Patents

Neparosan-n,0-sulfati i postupak za njihovo dobijanje

Info

Publication number
YU188691A
YU188691A YU188691A YU188691A YU188691A YU 188691 A YU188691 A YU 188691A YU 188691 A YU188691 A YU 188691A YU 188691 A YU188691 A YU 188691A YU 188691 A YU188691 A YU 188691A
Authority
YU
Yugoslavia
Prior art keywords
sulphates
parason
obtaining
sulfate
hydrogen atom
Prior art date
Application number
YU188691A
Other languages
English (en)
Other versions
YU48680B (sh
Inventor
J.C. Lormeau
B. Chevallier
M.L.V. Salome
G.E.M. Tenaille D'estais
Original Assignee
Elf Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elf Sanofi filed Critical Elf Sanofi
Priority to SI9111886A priority Critical patent/SI9111886B/sl
Priority to HRP920795 priority patent/HRP920795A2/hr
Publication of YU188691A publication Critical patent/YU188691A/sh
Publication of YU48680B publication Critical patent/YU48680B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

NEPAROSAN-N,0-SULFATI I POSTUPAK ZA NJIHOVO DOBIJANJE, pronalazak za objekt ima nove heparosan-N,O-sulfate sačinjene od lanca ili smeše lanca molekulske mase izmedju 1500 i 15000 Da, okarakterisane ponavljajućom disaharidnom strukturom, formule I: u kojoj, -E predstavlja u 0-80% disaharidnih jedinica heparosan-N,O-sulfata, acetil grupu i u ostalim disaharidnim jedinicama, sulfatnu grupu i eventualno atom vodonika, -G predstavlja atom vodonika i sulfatnu grupu, i njihove farmaceutski prihvatljive soli.
YU188691A 1990-12-03 1991-12-03 Heparosan-n,o-sulfati i postupak za njihovo dobivanje YU48680B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9111886A SI9111886B (sl) 1990-12-03 1991-12-03 Heparosan-N,O-sulfati, postopek za njihovo pridobivanje in farmacevtski preparati, ki jih vsebujejo
HRP920795 HRP920795A2 (en) 1991-12-03 1992-10-02 Heparosan-n, o-sulfates, the process for obtaining them and pharmaceutical preparations containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR909015114A FR2669932B1 (fr) 1990-12-03 1990-12-03 Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.

Publications (2)

Publication Number Publication Date
YU188691A true YU188691A (sh) 1994-05-10
YU48680B YU48680B (sh) 1999-06-15

Family

ID=9402838

Family Applications (1)

Application Number Title Priority Date Filing Date
YU188691A YU48680B (sh) 1990-12-03 1991-12-03 Heparosan-n,o-sulfati i postupak za njihovo dobivanje

Country Status (32)

Country Link
US (1) US5550116A (sh)
EP (1) EP0489647B1 (sh)
JP (1) JPH051101A (sh)
KR (1) KR100214752B1 (sh)
AR (1) AR248429A1 (sh)
AT (1) ATE150033T1 (sh)
AU (1) AU646112B2 (sh)
BG (1) BG60479B1 (sh)
BR (1) BR9105239A (sh)
CA (1) CA2056878A1 (sh)
CZ (1) CZ279081B6 (sh)
DE (1) DE69125109T2 (sh)
DK (1) DK0489647T3 (sh)
ES (1) ES2099145T3 (sh)
FI (1) FI103050B (sh)
FR (1) FR2669932B1 (sh)
GR (1) GR3023541T3 (sh)
HU (1) HU214986B (sh)
IE (1) IE914197A1 (sh)
IL (1) IL100229A (sh)
MX (1) MX9102353A (sh)
MY (1) MY109669A (sh)
NO (1) NO300277B1 (sh)
NZ (1) NZ240838A (sh)
PL (1) PL167668B1 (sh)
PT (1) PT99671B (sh)
RU (1) RU2099353C1 (sh)
SI (1) SI9111886B (sh)
SK (1) SK280642B6 (sh)
TW (1) TW216396B (sh)
YU (1) YU48680B (sh)
ZA (1) ZA919518B (sh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2254083A (en) * 1991-03-28 1992-09-30 Italfarmaco Spa Anticoagulants from e.coli saccharide
FR2684385B1 (fr) * 1991-11-28 1997-08-01 Sanofi Elf Heparosanes-n,o-sulfates de haute masse moleculaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
FR2709132B1 (fr) * 1993-08-17 1995-11-17 Sanofi Elf Fragment d'ADN portant le gène codant pour l'enzyme de fragmentation du N-acétylhéparosane et les séquences adjacentes permettant son expression, enzyme recombinée et son utilisation.
IT1282994B1 (it) * 1996-05-10 1998-04-03 Inalco Spa Derivati del polisaccaride k5 aventi elevata attivita' anticoagulante
IT1289613B1 (it) * 1997-02-07 1998-10-15 Inalco Spa Polisaccaridi batterici o-solfatati
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
US6329351B1 (en) * 1997-08-28 2001-12-11 Istituto Scientifico Di Chimica E Biochimica “G. Ronzoni” Semi-synthetic sulphaminoheparosansulphates having high anti-metastatic activity and reduced haemorrhagic risk
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20030161823A1 (en) * 1998-08-31 2003-08-28 Neta Ilan Therapeutic and cosmetic uses of heparanases
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
AU2878600A (en) * 1999-03-01 2000-09-21 Hadasit Medical Research Services & Development Company Ltd Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
ITMI991465A1 (it) * 1999-07-02 2001-01-02 Inalco Spa Processo per la preparazione dei polisaccaridi k4 e k5 da escherichiacoli
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
US20020062019A1 (en) * 2000-03-30 2002-05-23 Pasqua Oreste Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
US20050027117A1 (en) * 2000-12-18 2005-02-03 Pasqua Oreste Anticoagulant and antithrombotic LMW-glycosaminoglycans derived from K5 polysaccharide and process for their preparation
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
US8513407B2 (en) 2002-06-18 2013-08-20 Glycores 2000 S.R.L. Process for the preparation of N-acyl-(epi)K5-amine-O-sulfate-derivatives and products thus obtained
WO2003106506A1 (en) * 2002-06-18 2003-12-24 Pasqua Anna Oreste Low molecular weight oversulfated polysaccharide
WO2004108065A2 (en) * 2003-06-09 2004-12-16 Insight Biopharmaceuticals Ltd. Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
ITMI20031618A1 (it) * 2003-08-06 2005-02-07 Inalco Spa Derivati polisaccaridici dotati di alta attivita'
FR2874931B1 (fr) * 2004-09-08 2006-11-24 Aventis Pharma Sa Procede de production de polysaccharide k5
EP2473614A4 (en) * 2009-09-01 2013-04-24 Rensselaer Polytech Inst K5 HEPAROSAN FERMENTATION AND CLEANING
CN111725495B (zh) * 2020-06-04 2021-07-02 大连理工大学 一种含n、o原子的网状聚合物的自支撑锂硫正极材料及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211616A (en) * 1961-12-17 1965-10-12 Yosizawa Zensakn N, o-sulfated neutral-mucopolysaccharide
FR2538404B1 (sh) * 1982-12-28 1985-08-23 Anic Spa
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
EP0333243A3 (en) * 1988-03-10 1989-09-27 Akzo N.V. Sulphated k5 antigen and sulphated k5 antigen fragments
IT1217458B (it) * 1988-05-02 1990-03-22 Crinos Ind Farmacoriologica S Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche
FR2634485B1 (fr) * 1988-07-21 1992-02-28 Sanopi Glycosaminoglycanes selectivement o-acyles, leur preparation et compositions pharmaceutiques les contenant
NZ226835A (en) * 1988-11-04 1992-10-28 Andrew Boyle Weather proof lamp housing: adjustable angle retained by interengaging teeth

Also Published As

Publication number Publication date
GR3023541T3 (en) 1997-08-29
IL100229A (en) 1998-01-04
IE914197A1 (en) 1992-06-03
TW216396B (sh) 1993-11-21
EP0489647B1 (fr) 1997-03-12
CS366891A3 (en) 1992-09-16
FI915697A (fi) 1992-06-04
SI9111886A (sl) 1998-02-28
ZA919518B (en) 1992-08-26
RU2099353C1 (ru) 1997-12-20
FR2669932B1 (fr) 1994-07-01
EP0489647A3 (en) 1992-09-23
FI915697A0 (fi) 1991-12-03
DK0489647T3 (da) 1997-09-08
MX9102353A (es) 1992-06-01
YU48680B (sh) 1999-06-15
SK280642B6 (sk) 2000-05-16
NO914751D0 (no) 1991-12-03
IL100229A0 (en) 1992-09-06
FI103050B1 (fi) 1999-04-15
KR100214752B1 (ko) 1999-08-02
HUT60784A (en) 1992-10-28
PT99671A (pt) 1992-10-30
CZ279081B6 (en) 1994-12-15
PT99671B (pt) 1999-05-31
BG60479B1 (bg) 1995-05-31
MY109669A (en) 1997-03-31
BR9105239A (pt) 1992-08-18
SI9111886B (sl) 1999-12-31
KR920012103A (ko) 1992-07-25
AU8836191A (en) 1992-06-04
FR2669932A1 (fr) 1992-06-05
AR248429A1 (es) 1995-08-18
JPH051101A (ja) 1993-01-08
NO300277B1 (no) 1997-05-05
PL292624A1 (en) 1993-03-08
EP0489647A2 (fr) 1992-06-10
FI103050B (fi) 1999-04-15
ATE150033T1 (de) 1997-03-15
DE69125109T2 (de) 1997-08-28
AU646112B2 (en) 1994-02-10
BG95567A (en) 1994-03-31
PL167668B1 (pl) 1995-10-31
ES2099145T3 (es) 1997-05-16
NZ240838A (en) 1993-11-25
HU214986B (hu) 1998-08-28
DE69125109D1 (de) 1997-04-17
US5550116A (en) 1996-08-27
NO914751L (no) 1992-06-04
CA2056878A1 (en) 1992-06-04
HU913776D0 (en) 1992-02-28

Similar Documents

Publication Publication Date Title
YU188691A (sh) Neparosan-n,0-sulfati i postupak za njihovo dobijanje
YU27095A (sh) Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao medikamenata
YU26691A (sh) BORNO KISELINSKI ADUKTI RENIJUM DIOKSIM I TEHNICIJUM-99 m DIOKSIM KOMPLEKSA I PRIBOR ZA MARKIRANJE SA TEHNICIJUMOM 99 m I/ILI RADIONUKLEIDOM RENIJUMA
EP0274127A3 (en) Biologically degradable derivatives of poly(hydroxy alkyl)aminodicarboxylic acid, process for their preparation and their use for sustained release compositions
FR2684385B1 (fr) Heparosanes-n,o-sulfates de haute masse moleculaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
LU90297I2 (fr) Rivastigmine ses sels et dérivés pharmaceutiquement acceptables en particulier la rivastigmine sous forme d'hydrogénotartrate
DE69519031D1 (de) Neue Antibiotika und ihre enthaltende antibiotische Zusammensetzungen für die Inhibition gram positiven Bakterien und Mykoplasmen.
AU6845190A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapeutics
ES2058656T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y su uso en la prevencion o tratamiento del sida.
GEP19981357B (en) New Adenozine Derivatives, Prepatation Methods and Pharmaceutical Composit¬i¬ons Containing Them
HUP9900924A2 (hu) Szubsztituált 1-béta-D-arabinofuranozil-citozin származékok és alkalmazásuk tumorellenes gyógyszerkészítmények előállítására
EP0472467A3 (en) Lps-containing analgesics and veterinary analgesics
EP1020474A4 (en) OLIGOSACCHARID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
IL99760A0 (en) Galactomannan derivatives,their preparation and their use for coating or embedding medicinally active substances
ATE42279T1 (de) Guanidinobenzoesaeureesterderivate, ein verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
MX9302833A (es) Piridinas substituidas, proceso para su preparacion y composicion farmaceutica que las comprende.
ATE96444T1 (de) 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
IT1251160B (it) Impiego di composti adenosinici nel trattamento dell'ischemia
FR2379535A1 (fr) Nouveaux derives de l'ergoline, leurs applications en therapeutique et procede pour leur application
DE59101813D1 (de) Verfahren zur herstellung eines feinteiligen vinylchlorid-pfropfcopolymerisats.
ZA913644B (en) 3'-deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines and processes for their preparation
DK0434833T3 (da) 9-fluor-prostaglandinderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske anvendelse
DE69522585D1 (de) In 4-position substituierte 2,6-di-tert-butylphenole, diese enthaltende pharmazeutische compositionen und ihre herstellungsverfahren
YU47562B (sh) Benzotiazinski derivati i postupak za njihovo dobijanje
ATE144986T1 (de) Aminoacylderivate von gem- diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten